Anti-idiotype cancer vaccines: past and future D. HerlynRajasekharan SomasundaramHaruhiko Maruyama REVIEW Pages: 65 - 76
The neutrophil as an information transmitter in tumor inhibition by a streptococcal biological response modifier, OK-432 Tsukasa SatoYasuhiko MidorikawaF. Sendo ORIGINAL ARTICLE Pages: 77 - 86
Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patients T. HanagiriMitsuhiro TakenoyamaKosei Yasumoto ORIGINAL ARTICLE Pages: 87 - 93
The prognostic significance of immune changes in patients with renal cancer, melanoma and colorectal cancer, treated with interferon α2b N. TsavarisC. BaxevanisM. Papamichael ORIGINAL ARTICLE Pages: 94 - 102
Induction of graft versus leukemia effects by cell-mediated lymphokine-activated immunotherapy after syngeneic bone marrow transplantation in murine B cell leukemia Lola WeissSamir NusairS. Slavin ORIGINAL ARTICLE Pages: 103 - 108
Bcl-2 protects cells from cytokine-induced nitric-oxide-dependent apoptosis Keping XieSuyun HuangI. J. Fidler ORIGINAL ARTICLE Pages: 109 - 115
Immune response against medullary thyroid carcinoma (MTC) induced by parental and/or interleukin-2-secreting MTC cells in a rat model of human familial medullary thyroid carcinoma S. LaussonB. FournesF. Treilhou-Lahille ORIGINAL ARTICLE Pages: 116 - 123